BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 33612198)

  • 1. Exploring nonprescribed use of buprenorphine in the criminal justice system through qualitative interviews among individuals recently released from incarceration.
    Monico LB; Gryczynski J; Lee JD; Dusek K; McDonald R; Malone M; Sharma A; Cheng A; DeVeaugh-Geiss A; Chilcoat H
    J Subst Abuse Treat; 2021 Apr; 123():108267. PubMed ID: 33612198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of non-prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration.
    Gryczynski J; Lee JD; Dusek K; McDonald R; Sharma A; Malone M; Monico LB; Cheng A; DeVeaugh-Geiss A; Chilcoat HD
    J Subst Abuse Treat; 2021 Aug; 127():108349. PubMed ID: 34134866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts.
    Evans EA; Pivovarova E; Senthilkumar R; Rottapel RE; Stopka TJ; Santelices C; Ferguson WJ; Friedmann PD
    Int J Drug Policy; 2023 Dec; 122():104252. PubMed ID: 37980776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study.
    Cheng A; Badolato R; Segoshi A; McDonald R; Malone M; Vasudevan K; Badiei B; Sugarman A; Macdonald R; Mangat J; Giftos J; Lee JD; Tofighi B
    Addict Sci Clin Pract; 2022 Jan; 17(1):4. PubMed ID: 35093164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
    Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
    Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding buprenorphine in U.S. jails: One county's response to addressing the fears of diversion.
    Whaley S; Bandara S; Taylor K; Krawczyk N
    J Subst Use Addict Treat; 2023 Mar; 146():208944. PubMed ID: 36880899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does incarceration influence patients' goals for opioid use disorder treatment? A qualitative study of buprenorphine treatment in jail.
    Vail W; Faro E; Watnick D; Giftos J; Fox AD
    Drug Alcohol Depend; 2021 May; 222():108529. PubMed ID: 33810909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
    Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
    Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
    Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-specific participation and outcomes among jail diversion clients with co-occurring substance use and mental health disorders.
    Robertson AG; Easter MM; Lin HJ; Khoury D; Pierce J; Swanson J; Swartz M
    J Subst Abuse Treat; 2020 Aug; 115():108035. PubMed ID: 32600621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring prison buprenorphine misuse in the United Kingdom: a qualitative study of former prisoners.
    Tompkins CN; Wright NM; Waterman MG; Sheard L
    Int J Prison Health; 2009; 5(2):71-87. PubMed ID: 25759139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail.
    Evans EA; Pivovarova E; Stopka TJ; Santelices C; Ferguson WJ; Friedmann PD
    J Subst Abuse Treat; 2022 Jul; 138():108746. PubMed ID: 35249789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Threshold Telemedicine-based Opioid Treatment for Criminal Justice Involved Adults During the COVID-19 Pandemic: A Case Report.
    Flavin L; Tofighi B; Krawczyk N; Schatz D; McNeely J; Butner J
    J Addict Med; 2022 Jan-Feb 01; 16(1):e59-e61. PubMed ID: 35120069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters.
    Bandara S; Kennedy-Hendricks A; Merritt S; Barry CL; Saloner B
    Addiction; 2021 Dec; 116(12):3473-3481. PubMed ID: 33999458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injecting Opioid Use Disorder Treatment in Jails and Prisons: The Potential of Extended-release Buprenorphine in the Carceral Setting.
    Berk J; Del Pozo B; Rich JD; Lee JD
    J Addict Med; 2022 Jul-Aug 01; 16(4):396-398. PubMed ID: 34954747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medications for opioid use disorder in state prisons: Perspectives of formerly incarcerated persons.
    Treitler PC; Enich M; Reeves D; Crystal S
    Subst Abus; 2022; 43(1):964-971. PubMed ID: 35420973
    [No Abstract]   [Full Text] [Related]  

  • 17. Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder.
    Evans EA; Wilson D; Friedmann PD
    Drug Alcohol Depend; 2022 Feb; 231():109254. PubMed ID: 35063323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Evolving Medicolegal Precedent for Medications for Opioid Use Disorder in U.S. Jails and Prisons.
    Toyoshima T; McNiel DE; Schonfeld A; Binder R
    J Am Acad Psychiatry Law; 2021 Dec; 49(4):545-552. PubMed ID: 34341145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for incarcerated adults with opioid use disorder in the United States: A systematic review with a focus on social determinants of health.
    Sugarman OK; Bachhuber MA; Wennerstrom A; Bruno T; Springgate BF
    PLoS One; 2020; 15(1):e0227968. PubMed ID: 31961908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicaid Enrollment among Prison Inmates in a Non-expansion State: Exploring Predisposing, Enabling, and Need Factors Related to Enrollment Pre-incarceration and Post-Release.
    Grodensky CA; Rosen DL; Blue CM; Miller AR; Bradley-Bull S; Powell WA; Domino ME; Golin CE; Wohl DA
    J Urban Health; 2018 Aug; 95(4):454-466. PubMed ID: 29934825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.